Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 3
2007 2
2008 2
2010 1
2013 1
2014 6
2015 4
2016 4
2017 6
2018 3
2019 2
2020 3
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Results by year
Filters applied: . Clear all
Page 1
The expression of the long NEAT1_2 isoform is associated with human epidermal growth factor receptor 2-positive breast cancers.
Knutsen E, Lellahi SM, Aure MR, Nord S, Fismen S, Larsen KB, Gabriel MT, Hedberg A, Bjørklund SS; Oslo Breast Cancer Research Consortium (OSBREAC), Bofin AM, Mælandsmo GM, Sørlie T, Mortensen ES, Perander M. Knutsen E, et al. Among authors: bofin am. Sci Rep. 2020 Jan 28;10(1):1277. doi: 10.1038/s41598-020-57759-4. Sci Rep. 2020. PMID: 31992741 Free PMC article.
The prognostic value of androgen receptors in breast cancer subtypes.
Kraby MR, Valla M, Opdahl S, Haugen OA, Sawicka JE, Engstrøm MJ, Bofin AM. Kraby MR, et al. Among authors: bofin am. Breast Cancer Res Treat. 2018 Nov;172(2):283-296. doi: 10.1007/s10549-018-4904-x. Epub 2018 Aug 14. Breast Cancer Res Treat. 2018. PMID: 30109519
Quantifying tumour vascularity in non-luminal breast cancers.
Kraby MR, Opdahl S, Akslen LA, Bofin AM. Kraby MR, et al. Among authors: bofin am. J Clin Pathol. 2017 Sep;70(9):766-774. doi: 10.1136/jclinpath-2016-204208. Epub 2017 Mar 1. J Clin Pathol. 2017. PMID: 28249942
Basal markers and prognosis in luminal breast cancer.
Engstrøm MJ, Valla M, Bofin AM. Engstrøm MJ, et al. Among authors: bofin am. Breast Cancer Res Treat. 2017 Jun;163(2):207-217. doi: 10.1007/s10549-017-4182-z. Epub 2017 Mar 3. Breast Cancer Res Treat. 2017. PMID: 28258354
A novel non-canonical Wnt signature for prostate cancer aggressiveness.
Sandsmark E, Hansen AF, Selnæs KM, Bertilsson H, Bofin AM, Wright AJ, Viset T, Richardsen E, Drabløs F, Bathen TF, Tessem MB, Rye MB. Sandsmark E, et al. Among authors: bofin am. Oncotarget. 2017 Feb 7;8(6):9572-9586. doi: 10.18632/oncotarget.14161. Oncotarget. 2017. PMID: 28030815 Free PMC article.
SFRP4 gene expression is increased in aggressive prostate cancer.
Sandsmark E, Andersen MK, Bofin AM, Bertilsson H, Drabløs F, Bathen TF, Rye MB, Tessem MB. Sandsmark E, et al. Among authors: bofin am. Sci Rep. 2017 Oct 27;7(1):14276. doi: 10.1038/s41598-017-14622-3. Sci Rep. 2017. PMID: 29079735 Free PMC article.
39 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page